ATR
APTARGROUP, INC.
+0.78 (+0.63%)125.49USD92.1K成交股數8.0B市值22.7本益比(近四季)2.0股價營收比+6.3%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.0B+16% | 983M+16% | 961M+6% | 966M+6% | 887M-3% | 848M-5% | 909M+1% | 910M+6% | 915M | 893M | 896M | 860M |
| 營業成本 | 661M | 631M | 598M | 599M | 551M | – | 559M | 567M | – | – | – | – |
| 毛利 | 366M+9% | 352M | 363M+4% | 367M+7% | 336M | – | 351M | 343M | – | – | – | – |
| 毛利率 | 35.6% | 35.8% | 37.8% | 38.0% | 37.9% | – | 38.6% | 37.6% | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益 | 127M+12% | 107M-10% | 137M-1% | 144M+15% | 113M+1% | 120M+1% | 138M+19% | 126M+50% | 112M | 119M | 117M | 83.9M |
| 營業利益率 | 12.3% | 10.9% | 14.2% | 14.9% | 12.8% | 14.2% | 15.2% | 13.8% | 12.2% | 13.4% | 13.0% | 9.8% |
| 稅後淨利 | 87.6M+11% | 72.7M-28% | 128M+28% | 112M+24% | 78.8M-5% | 101M+20% | 100M+20% | 90.5M+65% | 83.1M | 84.3M | 83.1M | 54.8M |
| 淨利率 | 8.5% | 7.4% | 13.3% | 11.6% | 8.9% | 11.9% | 11.0% | 9.9% | 9.1% | 9.4% | 9.3% | 6.4% |
| 稀釋 EPS | 1.36+16% | 1.12-24% | 1.92+30% | 1.67+25% | 1.17-5% | 1.48+17% | 1.48+19% | 1.34+63% | 1.23 | 1.26 | 1.24 | 0.82 |
| 稀釋股數 | 64.2M | 64.8M | 66.6M | 67.0M | 67.5M | 67.7M | 67.7M | 67.6M | 67.4M | 67.0M | 66.9M | 66.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 190M | 223M | 257M | 162M | 126M | 224M | 326M | 221M | 200M | 152M | 121M | 127M |
| 應收帳款 | – | – | – | – | – | 658M | – | – | – | – | – | – |
| 存貨 | 580M | 551M | 547M | 527M | 484M | 462M | 489M | 485M | 497M | 491M | 516M | 513M |
| 總資產 | 5.1B | 5.1B | 5.1B | 4.9B | 4.5B | 4.4B | 4.6B | 4.5B | 4.4B | 4.3B | 4.3B | 4.3B |
| 有息負債 | 1.1B | 1.1B | 546M | 535M | 561M | 688M | 823M | 682M | 680M | 680M | 950M | 956M |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 2.6B | 2.6B | 2.8B | 2.7B | 2.5B | 2.5B | 2.5B | 2.4B | 2.3B | 2.2B | 2.2B | 2.1B |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −928M | −921M | −289M | −373M | −435M | −464M | −497M | −460M | −481M | −528M | −829M | −829M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 119M | – | – | 82.7M-10% | – | – | – | 92.3M | – | – | 98.3M |
| 資本支出 | – | 65.4M | – | – | 56.9M | – | – | – | 75.7M | – | – | 77.8M |
| 自由現金流 | – | 53.3M | – | – | 25.9M+55% | – | – | – | 16.7M | – | – | 20.5M |
| 折舊攤銷 | 79.6M | 75.7M | – | 69.9M | 65.6M | 67.5M | 67.0M | 65.0M | 64.3M | 62.7M | 62.3M | 59.3M |
| 買回庫藏股 | – | 100.0M | – | – | 80.0M | – | – | – | 12.1M | – | – | 19.7M |
| 現金股利 | – | 30.9M | – | – | 29.9M | – | – | – | 27.1M | – | – | 24.8M |
| 自由現金流率 | – | 5.4% | – | – | 2.9% | – | – | – | 1.8% | – | – | 2.4% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 3.8B
| Pharma | 1.7B | 45.7% | +5.7% |
|---|---|---|---|
| Beauty | 1.3B | 35.2% | +6.8% |
| Closures | 730M | 19.2% | +2.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.8B | +5.4% | 393M | 10.4% | 5.89 | 300M |
| FY2024 | 3.6B | +2.7% | 375M | 10.5% | 5.53 | 367M |
| FY2023 | 3.5B | +5.0% | 284M | 8.2% | 4.25 | 263M |
| FY2022 | 3.3B | +2.9% | 239M | 7.2% | 3.59 | 168M |
| FY2021 | 3.2B | +10.2% | 244M | 7.6% | 3.61 | 55.5M |
| FY2020 | 2.9B | +2.4% | 214M | 7.3% | 3.21 | 324M |
| FY2019 | 2.9B | +3.4% | 242M | 8.5% | 3.66 | 272M |
| FY2018 | 2.8B | – | 195M | 7.0% | 3.00 | 102M |